These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5236015)

  • 1. Properties of catapres, a new hypotensive drug: a preliminary report.
    Ng J; McGrgor DD; Taylor KM; Smirk H
    N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Moxonidine. A new centrally active antihypertensive drug].
    Schrader J; Molderings GJ; Dominiak P
    Internist (Berl); 1992 Oct; 33(10):704-6. PubMed ID: 1428688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
    Pozenel H
    Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
    [No Abstract]   [Full Text] [Related]  

  • 8. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological properties of aminoenanthylic acid].
    Gofman SM
    Farmakol Toksikol; 1968; 31(2):188-9. PubMed ID: 4386316
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in therapy. Antihypertensive and antibacterial agents.
    Brod J
    Prog Biochem Pharmacol; 1972; 7():324-69. PubMed ID: 4567422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Hukuhara T; Otsuka Y; Takeda R; Sukai F
    Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Moxonidine. A new antihypertensive agent of central action].
    Leães CG; Rosito GA
    Arq Bras Cardiol; 1998 Jun; 70(6):443-8. PubMed ID: 9713089
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
    Royds RB
    Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hypotensive effect of prazosin].
    Huysmans FT; Thien T; Rosier JG; van't Laar A; Koene RA
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1141-7. PubMed ID: 7402391
    [No Abstract]   [Full Text] [Related]  

  • 19. A preliminary evaluation of the sedative effects of catapres, a new antihypertensive agent, in chronic schizophrenic patients.
    Simpson GM; Kunz-Bartholini E; Watts TP
    J Clin Pharmacol J New Drugs; 1967; 7(4):221-5. PubMed ID: 5231438
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
    Seedat YK; Vawda EI; Mitha S; Ramasar R
    S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.